Acrylamide study sparks German debate

that implied levels of the carcinogen acrylamide in the body might not be as strongly influenced by consumption of acrylamide-containing food as is currently believed.

Written byNed Stafford
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Scientists from the University of Hanover Medical School in Germany recently published a study in Deutsches Ärzteblatt that implied levels of the carcinogen acrylamide in the body might not be as strongly influenced by consumption of acrylamide-containing food as is currently believed. The study, which sparked wide criticism among their peers, examined the association between hemoglobin adducts of acrylamide and the diet and smoking habits of 395 people. "No association was found between acrylamide adduct concentration and diet," they write.

Study coauthor Michael Bader, a chemist, says that participants completed questionnaires asking how often during the previous 120 days they had smoked cigarettes and consumed acrylamide-rich foods. Some 80% of participants carried acrylamide adducts in their blood, with levels only slightly higher in nonsmokers who ate acrylamide-rich foods more than once a week. A trend towards higher adduct concentration in heavy eaters of acrylamide did not reach statistical significance.

"I ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies